Spatial Transcriptomics: Mapping the Cellular Atlas

Technological Advances and Methodologies in Spatial Transcriptomics

Spatial transcriptomics represents a transformative leap in the field of molecular biology, enabling researchers to map gene expression across the spatial landscape of tissues. This technology bridges the gap between traditional histology and modern genomics, offering unprecedented insights into the spatial organization of cellular processes. The methodologies underlying spatial transcriptomics are diverse and rapidly evolving, driven by the need to address complex biological questions across various domains, from plant biology to human disease research.

Methodological Foundations and Innovations

Spatial transcriptomics is built upon the foundation of high-throughput sequencing technologies, which have been adapted to retain spatial information about the tissue samples being analyzed. The primary methodological approaches can be broadly categorized into two main types: in situ hybridization-based methods and capture-based sequencing techniques.

In Situ Hybridization-Based Methods: These techniques involve the direct labeling of RNA molecules within tissue sections using fluorescent probes. Methods such as multiplexed error-robust fluorescence in situ hybridization (MERFISH) and seqFISH+ allow for the simultaneous visualization of thousands of RNA species in their native tissue context. These approaches are particularly powerful for studying tissues where spatial context is critical, such as in the brain or during developmental processes.

Capture-Based Sequencing Techniques: These methods involve the physical capture of RNA molecules from tissue sections onto specialized slides, followed by sequencing. The pioneering work by Ståhl et al. introduced spatial transcriptomics as a technique where tissue sections are placed on slides with spatially barcoded oligonucleotides [1]. This allows for the capture of mRNA transcripts while preserving their spatial origin, which can then be sequenced to generate spatially resolved transcriptomic maps [2].

Biological Mechanisms and Applications

The application of spatial transcriptomics spans a wide range of biological systems, providing insights into cellular heterogeneity, tissue architecture, and disease mechanisms.

Cellular Heterogeneity and Tissue Architecture: One of the primary applications of spatial transcriptomics is the exploration of cellular diversity within tissues. By mapping gene expression across different regions, researchers can identify distinct cell types and states, as well as their spatial relationships. This is particularly important in complex tissues such as the brain, where understanding the spatial arrangement of neurons and glial cells is crucial for elucidating brain function and pathology.

Disease Mechanisms: Spatial transcriptomics has been instrumental in advancing our understanding of various diseases, including cancer and cardiovascular diseases. In oncology, spatial transcriptomics allows for the mapping of tumor microenvironments, revealing the spatial distribution of immune cells and cancer-associated fibroblasts, which can influence tumor progression and response to therapy. In cardiovascular research, spatial transcriptomics has been used to map the cellular composition of heart tissues, providing insights into the molecular mechanisms underlying heart disease [2].

Plant Biology: Although historically lagging behind animal and human research, spatial transcriptomics is beginning to revolutionize plant biology. This technology enables the study of plant tissues at a single-cell level, allowing for the identification of cell types and the reconstruction of developmental lineages. Such insights are crucial for understanding plant growth, development, and responses to environmental stresses [3].

Challenges and Future Directions

Despite its transformative potential, spatial transcriptomics faces several challenges that need to be addressed to fully realize its capabilities.

Computational Burden: The high-dimensional data generated by spatial transcriptomics requires sophisticated computational tools for analysis. Integrating spatial data with other omics layers, such as genomics and proteomics, poses additional challenges in terms of data integration and interpretation [4]. Advances in machine learning and deep learning are being leveraged to develop more efficient algorithms for data analysis, which will be crucial for handling the increasing complexity of spatial transcriptomic datasets.

Cost and Accessibility: The cost of spatial transcriptomics remains a significant barrier to widespread adoption. However, as with many new technologies, it is expected that costs will decrease over time, making these methods more accessible to a broader range of research groups [1]. Efforts to streamline workflows and reduce reagent costs are ongoing, which will be essential for democratizing access to this powerful technology.

Integration with Multi-Omics: The integration of spatial transcriptomics with other omics technologies, such as proteomics and metabolomics, holds great promise for providing a more comprehensive understanding of biological systems. Multi-omics approaches can reveal the interplay between different molecular layers, offering insights into the regulatory networks that govern cellular function and disease processes [2]. Developing robust frameworks for multi-omics integration will be a key focus of future research in this area.

Technological Innovations: Continued technological innovation is essential for advancing spatial transcriptomics. Improvements in spatial resolution, sensitivity, and throughput will enable more detailed and comprehensive mapping of tissues. Emerging techniques, such as 4D imaging and advanced microscopy, are poised to enhance the capabilities of spatial transcriptomics, allowing for dynamic studies of gene expression over time and space.

Conclusion

Spatial transcriptomics represents a paradigm shift in the study of gene expression, offering a powerful tool for mapping the cellular atlas of tissues. The technological advances and methodologies in this field are rapidly evolving, driven by the need to address complex biological questions across diverse research domains. While challenges remain, the continued development of computational tools, reduction in costs, and integration with multi-omics technologies will be crucial for unlocking the full potential of spatial transcriptomics. As these methodologies mature, they hold the promise of transforming our understanding of cellular and tissue biology, with profound implications for both basic research and clinical applications.

Applications of Spatial Transcriptomics in Understanding Tissue Architecture

Introduction to Spatial Transcriptomics

Spatial transcriptomics has emerged as a transformative technology in the field of genomics, offering unprecedented insights into the spatial organization of tissues at the molecular level. By enabling the visualization of gene expression within the spatial context of intact tissue sections, spatial transcriptomics bridges the gap between molecular biology and histology, allowing researchers to map the cellular architecture of complex tissues with high resolution and precision. This capability is crucial for understanding the intricate interplay between different cell types and their microenvironments, which is fundamental to both normal tissue function and disease pathology.

Methodologies in Spatial Transcriptomics

The methodologies underlying spatial transcriptomics involve a combination of advanced sequencing technologies and computational tools designed to capture and analyze spatially resolved gene expression data. Two primary approaches are typically employed: in situ sequencing and spatially resolved RNA sequencing.

In Situ Sequencing: This method involves sequencing RNA molecules directly within fixed tissue sections, preserving the spatial context of gene expression. The technique utilizes barcoded probes that hybridize to target RNA sequences, followed by sequencing-by-synthesis to identify the expressed genes. This approach, as demonstrated in the study by Langseth et al. [5], allows for the precise mapping of gene expression across tissue layers, providing a detailed view of cellular heterogeneity and organization.

Spatially Resolved RNA Sequencing: This approach involves capturing RNA from spatially defined regions of a tissue section using techniques such as laser capture microdissection or microfluidic devices. The captured RNA is then sequenced to obtain spatially resolved gene expression profiles. The integration of these profiles with single-cell RNA sequencing data enables the reconstruction of spatial maps of cell types and their interactions within the tissue, as seen in the GBmap study [6].

Biological Mechanisms and Insights

Spatial transcriptomics has provided critical insights into the biological mechanisms underlying tissue architecture and function. By mapping gene expression within the spatial context of tissues, researchers can uncover the molecular signatures of different cell types and their interactions with the surrounding microenvironment.

Cellular Heterogeneity and Tissue Niches: One of the key applications of spatial transcriptomics is the identification of cellular heterogeneity within tissues. In the context of glioblastoma (GB), a highly aggressive brain tumor, spatial transcriptomics has revealed extensive cellular diversity, including rare cell populations such as tumor-associated neutrophils and homeostatic microglia [6]. The study identified seven distinct tumor niches, each characterized by unique gene expression profiles and associated with specific clinical outcomes [6].

Anatomical Organization of the Brain: In the human cortex, spatial transcriptomics has been used to map the spatial distribution of 75 distinct cell types, providing a comprehensive atlas of cortical cell architecture [5]. This work has elucidated the precise within- and across-layer distributions of cell types, offering a deeper understanding of the functional organization of the brain [5].

Contextual Applications and Implications

The applications of spatial transcriptomics extend beyond basic research, offering significant implications for clinical and translational medicine. By providing a spatially resolved view of gene expression, spatial transcriptomics can inform the development of targeted therapies and personalized medicine approaches.

Cancer Research and Treatment: In cancer research, spatial transcriptomics has the potential to revolutionize the understanding of tumor biology and treatment response. The GBmap study demonstrated that highly organized tumors, characterized by well-defined vasculature and hypoxic niches, are associated with worse survival outcomes [6]. This finding highlights the importance of spatial organization in tumor progression and the potential for targeting specific niches to improve therapeutic outcomes.

Neuroscience and Brain Disorders: In neuroscience, the spatial mapping of cortical cell types provides a valuable resource for studying brain disorders. The comprehensive atlas of human cortical cells serves as a reference for investigating the cellular basis of neurological diseases, such as Alzheimer's and Parkinson's disease [5]. By understanding the spatial distribution of affected cell types, researchers can develop more effective strategies for diagnosis and treatment.

Integration with Other Technologies

Spatial transcriptomics is often integrated with other high-throughput technologies to enhance its analytical power. The combination of spatial transcriptomics with single-cell RNA sequencing, for example, allows for the detailed characterization of cell types and their spatial relationships within tissues. This integrative approach facilitates the construction of comprehensive cellular atlases, such as the GBmap [7] and the human cortical atlas [8], which serve as invaluable resources for the scientific community.

Conclusion

Spatial transcriptomics represents a paradigm shift in the study of tissue architecture, offering a powerful tool for mapping the cellular landscape of complex tissues. By providing spatially resolved gene expression data, this technology enables researchers to unravel the intricate relationships between cell types and their microenvironments, advancing our understanding of both normal tissue function and disease pathology. As spatial transcriptomics continues to evolve, its applications are expected to expand, providing new insights into the molecular basis of health and disease and paving the way for novel therapeutic approaches.

Integrating Spatial Transcriptomics with Other Omics for Comprehensive Cellular Mapping

The integration of spatial transcriptomics with other omics technologies represents a significant advancement in the field of cellular mapping, offering unparalleled insights into the spatial organization and functional dynamics of tissues. This comprehensive approach enables researchers to construct detailed cellular atlases that capture the complexity of biological systems at multiple levels, from gene expression to protein interactions and beyond. The following analysis delves into the methodologies, biological mechanisms, and contextual applications of integrating spatial transcriptomics with other omics, drawing on recent studies and authoritative resources.

Methodological Approaches to Integration

Spatial transcriptomics (ST) provides a spatially resolved map of gene expression within tissue sections, allowing researchers to pinpoint where specific transcripts are located. However, to fully understand the cellular microenvironment, it is crucial to integrate ST data with other omics approaches, such as proteomics, epigenomics, and metabolomics.

1. Spatial Multi-Omics Platforms

Recent advancements have led to the development of platforms like MERFISH+ and GeoMx Digital Spatial Profiler, which integrate spatial transcriptomics with proteomic data. MERFISH+, for instance, combines chemical probe anchoring with high-throughput microfluidics to map gene expression and chromatin organization in 3D at subcellular resolution, as demonstrated in the developing human heart. This integration allows for the simultaneous quantification of thousands of genes and the spatial organization of chromatin loci, providing a holistic view of tissue architecture.

GeoMx DSP, on the other hand, enables the spatial quantification of both protein and transcript levels within tissue sections. By leveraging this technology, researchers can dissect the spatial heterogeneity of complex tissues, such as glioblastoma, revealing distinct molecular signatures across tumor and normal brain regions [9].

2. Computational Integration Frameworks

The integration of spatial and single-cell omics data requires sophisticated computational frameworks. TOAST (Topography-aware Optimal Alignment of Spatially-resolved Tissues) is one such framework that enhances the alignment of spatially resolved tissue slices by incorporating spatial coherence and neighborhood consistency into its objective function [10]. This approach significantly improves the biological interpretability of spatially resolved omics data, facilitating multimodal data integration.

Another computational tool, NicheCompass, employs graph deep learning to identify and characterize cell niches based on spatial omics data. It quantifies the activity of spatial gene programs, uncovering the cellular processes that define each niche. Such tools are essential for integrating diverse omics datasets, enabling a more comprehensive understanding of tissue architecture.

Biological Mechanisms and Applications

The integration of spatial transcriptomics with other omics technologies provides insights into the biological mechanisms underlying tissue organization and function. This approach has been applied to various biological contexts, from understanding disease progression to mapping developmental processes.

1. Disease Mechanisms and Therapeutic Targets

In the context of Alzheimer's disease (AD), spatial transcriptomics has been combined with proteomics and other omics to map the brain's microenvironment, revealing spatially restricted dysregulation of neurons, microglia, and astrocytes [7]. This integration has identified biomarkers such as microglial TREM2 and endothelial LRP1, which guide therapeutic interventions and patient stratification for anti-amyloid therapies.

Similarly, in cancer research, integrating spatial transcriptomics with proteomics and metabolomics has elucidated the complex interactions within tumor microenvironments. For instance, in gastric cancer, this approach has revealed dynamic remodeling of the tumor microenvironment, characterized by the expansion of dysfunctional immune cells and pro-tumorigenic fibroblasts. Such insights are critical for developing targeted therapies and prognostic models.

2. Developmental Biology and Tissue Architecture

Spatial multi-omics has also been instrumental in mapping developmental processes. In the developing human heart, MERFISH+ has provided a 3D molecular atlas, capturing the spatial organization of cellular neighborhoods and transcriptional gradients. This comprehensive mapping enables researchers to understand the developmental cues that guide organogenesis.

In another study, the spatial organization of luminal epithelial cells in the murine prostate was mapped using spatial transcriptomics and multi-omics data, revealing transcriptional specificity and spatial distribution patterns [11]. Such studies highlight the potential of spatial multi-omics to uncover the developmental origins of cellular diversity.

Contextual Considerations and Future Directions

The integration of spatial transcriptomics with other omics technologies is not without challenges. Issues such as resolution limits, data complexity, and high costs must be addressed to fully realize the potential of this approach. However, advancements in AI-driven analysis and novel platforms promise to overcome these hurdles [7].

Authoritative resources like the Human Protein Atlas provide valuable datasets for integrating spatial transcriptomics with proteomics, enhancing our understanding of protein localization and function in health and disease [12]. Collaborative efforts and open-access datasets, such as those provided by the NCBI and other organizations, are crucial for advancing research in this field.

In conclusion, the integration of spatial transcriptomics with other omics technologies offers a powerful framework for comprehensive cellular mapping. By combining diverse data types, researchers can construct detailed cellular atlases that capture the complexity of biological systems, paving the way for personalized medicine and targeted therapeutic interventions. As methodologies and computational tools continue to evolve, the potential applications of spatial multi-omics in understanding health and disease are vast and promising.

Challenges and Limitations in Current Spatial Transcriptomics Approaches

Spatial transcriptomics (ST) has emerged as a transformative technology in the field of genomics, providing unprecedented insights into the spatial organization of gene expression within tissues. Despite its potential, the field faces several significant challenges and limitations that impede its broader application and the realization of its full potential. This section delves into these challenges, exploring the technical, biological, and computational hurdles that researchers encounter in the realm of spatial transcriptomics.

Technical Challenges in Spatial Transcriptomics

Resolution and Sensitivity

One of the primary technical challenges of spatial transcriptomics lies in its resolution and sensitivity. While imaging-based ST technologies have achieved single-cell spatial resolution, they are often limited by their gene detection capacity and the accuracy of expression measurements [13]. The spatial resolution is crucial for accurately mapping gene expression to specific cell types and understanding cellular interactions within the tissue microenvironment. However, the current technologies often require a trade-off between resolution and the number of genes that can be detected, which can lead to incomplete or biased datasets [14].

Tissue Processing and Preservation

The preparation and preservation of tissue samples pose another significant challenge. For instance, in bone research, the necessity for tissue decalcification and processing can complicate the application of ST, potentially affecting the integrity of the RNA and the spatial context [15]. The preservation methods must maintain the native architecture of the tissue while allowing for accurate gene expression profiling, a balance that is difficult to achieve consistently across different tissue types and conditions.

Platform Limitations and Workflow Bottlenecks

The intrinsic limitations of current ST platforms and the complexity of the workflows involved also present substantial challenges. Each platform has its own set of advantages and limitations, which can affect the choice of technology based on the specific research question and tissue type [15]. Moreover, the workflows for ST data generation and analysis are often complex and time-consuming, requiring meticulous optimization and standardization to ensure reproducibility and accuracy.

Computational and Analytical Challenges

Data Integration and Interpretation

The integration and interpretation of spatial transcriptomics data are fraught with challenges, particularly when combining data from multiple omics layers. The integration of spatial transcriptomics with other omics data, such as proteomics and metabolomics, is essential for a comprehensive understanding of biological systems. However, current approaches often rely on dimensionality reduction techniques that can disregard spatial context, limiting interpretability and scalability. The development of frameworks like INLAomics and EDGES aims to address these limitations by incorporating spatial information and ensuring that predicted gene expressions align closely with real ST distributions.

Imputation and Missing Data

Imputation of missing gene expression data is a critical challenge in ST. Methods such as stImpute attempt to overcome these limitations by using reference scRNA-seq data and gene networks constructed from protein language models [13]. However, these methods face challenges regarding prediction accuracy and the identification of cell populations, often due to the neglect of gene-gene relationships. Ensuring robust and accurate imputation remains a significant hurdle in the field.

Spatial Domain Recognition

Recognizing spatial domains within tissues is fundamental for interpreting ST data, yet it remains a major challenge. Current methods often rely on local spatial priors and lack the ability to capture long-range functional relationships, limiting their effectiveness in resolving biologically meaningful architectures [16]. Tools like SAGE aim to address these gaps by integrating non-negative matrix factorization with classifier-based importance scoring to identify spatially informative genes and reveal functionally coherent regions [17].

Biological and Contextual Challenges

Cellular Heterogeneity and Microenvironment Complexity

The inherent heterogeneity of tissues and the complexity of the microenvironment present significant biological challenges in spatial transcriptomics. For example, in cancer research, the heterogeneity of tumors [18] complicates the analysis of gene expression patterns and cellular interactions [19]. Understanding the spatial organization of different cell types and their interactions within the tumor microenvironment is crucial for unraveling the mechanisms of tumor progression and treatment response [20].

Cell-Cell Communication

Inferring cell-cell communication from ST data is a complex task, with over 100 bioinformatics tools developed to address this challenge. These tools vary widely in their assumptions and limitations, making it difficult to identify compatible and suitable resources for specific research needs. The complexity of cell-cell communication inference highlights the need for more comprehensive and integrative approaches that can accurately capture the dynamic interactions within tissues.

Future Directions and Prospects

Despite these challenges, the field of spatial transcriptomics holds immense promise for advancing our understanding of complex biological systems. Future research must focus on developing more robust and scalable computational methods that integrate spatial context and multiple omics layers. The integration of artificial intelligence and machine learning approaches could enhance the efficiency of data processing and interpretation, providing new insights into cellular heterogeneity and tissue architecture [19].

Furthermore, the standardization of tissue processing and preservation methods, along with the development of more versatile and user-friendly ST platforms, will be crucial for the widespread adoption of this technology. Continued collaboration between researchers, bioinformaticians, and clinicians will be essential for overcoming the current limitations and realizing the full potential of spatial transcriptomics in both research and clinical settings.

In conclusion, while spatial transcriptomics faces several significant challenges, ongoing advancements in technology and methodology are paving the way for its broader application and impact. By addressing these challenges, researchers can unlock new possibilities for understanding the spatial organization of gene expression and its implications for health and disease.

Future Directions and Innovations in Spatial Transcriptomics Research

Spatial transcriptomics (ST) has rapidly evolved as a pivotal technology in the realm of molecular biology, offering unprecedented insights into the spatial organization of gene expression within tissues. This capability is particularly transformative in complex diseases like Alzheimer's disease (AD), where the spatial context of cellular interactions is crucial for understanding pathophysiology [21]. As we look toward the future, several promising directions and innovations in ST research are poised to further enhance our understanding of cellular microenvironments, not only in AD but across a wide array of biological contexts.

Advancements in Resolution and Sensitivity

One of the primary challenges in current ST methodologies is the resolution limit, which constrains the ability to map gene expression at a single-cell level within complex tissues. Future innovations are likely to focus on enhancing the spatial resolution and sensitivity of ST techniques. Emerging technologies such as STORM-seq, which combines super-resolution microscopy with sequencing, offer a glimpse into the potential of achieving near-single-cell resolution [21]. These advancements will enable researchers to dissect cellular heterogeneity with greater precision, facilitating the identification of rare cell types and subtle cellular interactions that are critical in disease pathology.

Integration with Multi-Omics Approaches

The integration of ST with other omics technologies, such as proteomics, metabolomics, and epigenomics, represents a significant future direction. This multi-omics approach will provide a more comprehensive view of the molecular landscape within tissues, capturing not only transcriptomic data but also the proteomic and metabolic states of cells. Such integration is particularly valuable in diseases like AD, where the interplay between genetic, proteomic, and metabolic factors is complex and multifaceted [21]. By correlating spatial transcriptomic data with proteomic and metabolic profiles, researchers can gain deeper insights into disease mechanisms and identify novel therapeutic targets.

AI-Driven Data Analysis

The complexity and volume of data generated by ST technologies necessitate advanced analytical tools for effective interpretation. Artificial intelligence (AI) and machine learning (ML) are expected to play a crucial role in future ST research by enabling the automated analysis of large datasets. AI-driven algorithms can identify patterns and correlations within the data that may not be apparent through traditional analytical methods. In the context of AD, AI can help uncover spatial patterns of gene expression associated with disease progression and response to therapies, thereby informing the development of precision medicine approaches [21].

Development of Novel Platforms

The evolution of novel ST platforms is another exciting area of future research. These platforms aim to overcome current limitations related to cost, scalability, and ethical concerns. For instance, the development of cost-effective and high-throughput ST platforms will democratize access to this technology, enabling broader application across various research fields. Furthermore, ethical considerations, particularly in human tissue research, will drive the development of platforms that ensure data privacy and compliance with regulatory standards.

Bridging Basic Research and Clinical Practice

A critical future direction for ST research is the translation of basic research findings into clinical practice. The ability of ST to map cellular dysregulation in diseases like AD holds significant promise for the development of diagnostic and therapeutic innovations. For example, biomarkers identified through ST, such as microglial TREM2 and endothelial LRP1, can guide patient stratification for targeted therapies [21]. Additionally, ST can facilitate early detection of diseases through the identification of subtle changes in specific brain regions, such as the entorhinal cortex in AD. By bridging the gap between research and clinical application, ST has the potential to redefine disease management and improve patient outcomes.

Collaborative Research and Open-Access Data

The collaborative nature of ST research is expected to expand, driven by the availability of open-access datasets and comprehensive atlases. Platforms like the Gene Expression Omnibus (GEO) and brain atlases provide valuable resources for researchers, fostering collaboration and accelerating discoveries [21]. Future efforts will likely focus on enhancing the accessibility and interoperability of these datasets, enabling researchers worldwide to contribute to and benefit from shared knowledge. Such collaborative endeavors will be instrumental in advancing our understanding of complex diseases and developing innovative solutions.

Ethical and Regulatory Considerations

As ST technologies continue to evolve, ethical and regulatory considerations will play an increasingly important role in guiding research practices. The collection and analysis of spatial transcriptomic data, particularly from human tissues, raise important ethical questions related to consent, data privacy, and the potential for misuse. Future research will need to address these concerns by developing robust ethical frameworks and regulatory guidelines that ensure the responsible use of ST technologies. Organizations such as the World Health Organization (WHO) and the National Center for Biotechnology Information (NCBI) may play a pivotal role in establishing these guidelines, ensuring that ST research is conducted in a manner that respects individual rights and societal values.

Conclusion

The future of spatial transcriptomics research is rich with potential, driven by advancements in technology, integration with multi-omics approaches, and the application of AI-driven analysis. As ST continues to evolve, it will provide deeper insights into the spatial organization of gene expression, enhancing our understanding of complex diseases and informing the development of precision medicine strategies. Collaborative research efforts and ethical considerations will be critical in ensuring that these innovations are translated into tangible benefits for society, paving the way for a new era of personalized healthcare.

References

[1] Single Cell Sequencing and Spatial Transcriptomics in Kidney Transplantation. DOI: 10.1007/s40472-024-00450-8

[2] Multi-Omics Approaches to Cardiovascular Disease: Technological Innovations and Clinical Translation. DOI: 10.1152/ajpheart.00024.2026

[3] Spatial transcriptomics drives a new era in plant research.. DOI: 10.1111/tpj.16437

[4] Single-cell spatial (scs) omics Recent developments in data analysis. DOI: 10.1016/j.trac.2024.118109

[5] Comprehensive in situ mapping of human cortical transcriptomic cell types. DOI: 10.1038/s42003-021-02517-z

[6] Charting the single-cell and spatial landscape of IDH-wild-type glioblastoma with GBmap. DOI: 10.1093/neuonc/noaf113

[7] Spatial transcriptomics in Alzheimer's disease: Mapping cellular dysregulation in the brain microenvironment. DOI: 10.53771/ijbpsa.2025.10.1.0064

[8] Spatial transcriptomics in health and disease. DOI: 10.1038/s41581-024-00841-1

[9] Abstract 4971: Integrated spatial multiomic mapping of glioblastoma microenvironments via proteomic and transcriptomic profiling. DOI: 10.1158/1538-7445.am2026-4971

[10] Topography-aware optimal transport for alignment of spatial omics data. DOI: 10.1101/2025.04.15.648894

[11] Abstract A067: Cellular cartography reveals transcriptional specificity and spatial organization of diverse luminal epithelial cells in the murine prostate. DOI: 10.1158/1538-7445.prca2023-a067

[12] The Human Protein Atlas, Spatial localization of the human proteome in health and disease. DOI: 10.1002/pro.3987

[13] Imputing spatial transcriptomics through gene network constructed from protein language model. DOI: 10.1038/s42003-024-06964-2

[14] Enhancing Spatial Transcriptomics via Spatially Constrained Matrix Decomposition with EDGES. DOI: 10.1002/advs.202508346

[15] Spatial transcriptomics in bone research: navigating hype and hurdles.. DOI: 10.1016/j.pathol.2025.10.003

[16] Multi-modal Spatial Clustering for Spatial Transcriptomics Utilizing High-resolution Histology Images. DOI: 10.1109/BIBM62325.2024.10822051

[17] SAGE: Spatially Aware Gene Selection and Dual‐View Embedding Fusion for Domain Identification in Spatial Transcriptomics. DOI: 10.1002/advs.202520333

[18] Multiomics in Renal Cell Carcinoma: Current Landscape and Future Directions for Precision Medicine. DOI: 10.1007/s11934-025-01276-2

[19] Data enhancement in the age of spatial biology.. DOI: 10.1016/bs.acr.2024.06.008

[20] Multidimensional decoding of colorectal cancer heterogeneity: Artificial intelligence-enabled precision exploration of single-cell and spatial transcriptomics. DOI: 10.4251/wjgo.v17.i10.110661

[21] Spatial transcriptomics in Alzheimer's disease: Mapping cellular dysregulation in the brain microenvironment. DOI: 10.53771/ijbpsa.2025.10.1.0064 *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.